U.S. markets closed

Ekso Bionics Holdings, Inc. (EKSO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.52+0.56 (+9.40%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/7/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
78.88M51.18M39.50M65.64M16.54M
Enterprise Value 3
69.87M40.49M30.09M60.32M9.55M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
5.053.792.453.680.97
Price/Book (mrq)
17.796.09N/A12.562.43
Enterprise Value/Revenue 3
7.8717.9610.3926.646.51
Enterprise Value/EBITDA 7
-4.64-10.6711.49-5.21-4.12

Trading Information

Stock Price History

Beta (5Y Monthly) 2.28
52-Week Change 3105.68%
S&P500 52-Week Change 349.51%
52 Week High 314.98
52 Week Low 32.67
50-Day Moving Average 36.74
200-Day Moving Average 36.39

Share Statistics

Avg Vol (3 month) 3482.49k
Avg Vol (10 day) 3864.63k
Shares Outstanding 512.6M
Implied Shares Outstanding 6N/A
Float 11.07M
% Held by Insiders 17.73%
% Held by Institutions 19.47%
Shares Short (Mar 14, 2021) 4181.82k
Short Ratio (Mar 14, 2021) 40.45
Short % of Float (Mar 14, 2021) 41.55%
Short % of Shares Outstanding (Mar 14, 2021) 41.44%
Shares Short (prior month Feb 11, 2021) 4205.74k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 24, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Mar 24, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin -178.17%
Operating Margin (ttm)-144.76%

Management Effectiveness

Return on Assets (ttm)-37.81%
Return on Equity (ttm)-281.81%

Income Statement

Revenue (ttm)8.88M
Revenue Per Share (ttm)1.24
Quarterly Revenue Growth (yoy)-39.40%
Gross Profit (ttm)5.07M
EBITDA -12.24M
Net Income Avi to Common (ttm)-15.82M
Diluted EPS (ttm)-2.21
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.86M
Total Cash Per Share (mrq)1.02
Total Debt (mrq)3.86M
Total Debt/Equity (mrq)86.96
Current Ratio (mrq)3.70
Book Value Per Share (mrq)0.53

Cash Flow Statement

Operating Cash Flow (ttm)-8.76M
Levered Free Cash Flow (ttm)-2.84M